TODAY'S HEADLINES
Boehringer Ingelheim is facing lawsuits in the United States over claims that dabigatran etexilate mesylate (Pradaxa) capsules, a blood-thinner used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem, causes severe and fatal bleeding. » More |
|
More than 14% of pregnant women were prescribed opioids for pain at some time during their pregnancy, according to a study published online in Anesthesiology. » More |
|
Michigan will be the first state to standardize concentrations for children’s liquid prescriptions, due to a statewide initiative to reduce pediatric medication errors. » More |
|
Nearly 12% of Medicare patients who receive inpatient rehabilitation following discharge from acute-care hospitalization are readmitted to the hospital within 30 days after discharge from the rehabilitation facility, according to a study in the Journal of the American Medical Association. » More |
Continuing Education
Drug Topics kicks off a new CPE series, MTM Considerations for Adult Patients with Cardiovascular Disease, which will include 12 knowledge-based activities worth up to 24 credits. The goal of the first activity, “MTM essentials for cholesterol management,” will empower pharmacists to utilize current understanding of cholesterol management to improve patient care. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career. |
|
|
Like
Tweet
